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Introduction
The gold standard for surgical treatment of ad-
renal tumours is laparoscopic adrenalectomy [1, 2]. 
Over the last two decades it has systematically re-
placed open procedures due to the multiple benefits 
of a minimally invasive approach. It has been proven 
that laparoscopic adrenalectomy hastens convales-
cence, reduces length of hospital stay (LOS) and, 
most importantly, lowers the morbidity rate [3, 4]. 
Even though laparoscopic adrenalectomy is currently 
a standard, there is considerable variation between 
different centres in short-term treatment results, 
such as LOS or morbidity [5]. Median LOS varies 
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A b s t r a c t
Introduction: Even though laparoscopic adrenalectomy is currently a standard, there are important variations be-
tween different centres in short-term treatment results such as length of hospital stay (LOS) or morbidity. 
Aim: To determine the factors affecting LOS in patients after laparoscopic transperitoneal lateral adrenalectomy (LTA).
Material and methods: The study enrolled 453 patients (173 men and 280 women, mean age 57 years) who under-
went LTA between 2009 and 2017. Discharge from hospital after more than median hospital stay was considered 
as prolonged LOS. We evaluated factors that potentially may influence LOS (primary length of stay after surgery, 
excluding readmissions). Logistic regression models were used in univariate and corrected multivariate analyses, in 
order to identify the factors related to prolonged LOS. 
Results: The median LOS after LTA in the studied group was 2 days. One hundred seventy-five (38.5%) patients 
required prolonged hospitalization. Univariate logistic regression showed that the following factors were related 
to prolonged LOS: presence of any comorbidity, cardiovascular disease, intraoperative complications, postopera-
tive complications, day of the week of operation (surgery on Thursday or Friday), intraoperative blood loss, need 
for transfusion, hormonal activity, postoperative drainage, ASA (III–IV) and histological type – pheochromocytoma. 
Multivariate logistic regression showed that only complications (OR = 3.86; 95% CI: 1.84–8.04), day of the week of 
operation (Thursday or Friday) (OR = 4.85; 95% CI: 3.04–7.73), need for drainage (OR = 3.63; 95% CI: 1.55–8.52), 
and histological type – pheochromocytoma (OR = 2.48; 95% CI: 1.35–4.54) prolonged LOS.
Conclusions: Prolonged length of hospital stay following laparoscopic transperitoneal lateral adrenalectomy is 
strongly associated with the presence of postoperative complications, day of the week of operation (Thursday or 
Friday), need for drainage, and histological type – pheochromocytoma.
Key words: laparoscopy, adrenalectomy, adrenal tumour, prolonged hospitalization.
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from 2 to 8 days, whereas morbidity rates, according 
to some authors, range from 4% to 23% [6–8]. All 
of the above prompted us to identify which factors 
may potentially cause these differences.
Aim
The aim of this study was to determine the fac-
tors affecting LOS in patients after laparoscopic 
transperitoneal lateral adrenalectomy (LTA).
Material and methods
The prospective study included consecutive pa-
tients undergoing elective laparoscopic transperito-
neal adrenalectomy from 2009 to 2017 in the 2nd De-
partment of General Surgery. Patients who initially 
underwent open surgery or patients with an inoper-
able tumour with distant metastases were excluded 
from the study. 
Our department is a  tertiary referral universi-
ty unit. Annually more than 700 laparoscopic pro-
cedures are performed – mainly gastric, bariatric, 
colorectal, pancreatic and hepatobiliary surgeries, 
with more than 60 cases of adrenalectomy [9, 10]. 
Since 2003 a  laparoscopic approach has been the 
preferred access for adrenalectomy in our unit. How-
ever, in selected cases single access laparoscopy has 
been used [11, 12]. 
All patients had preoperative evaluation includ-
ing imaging: most commonly computed tomog-
raphy. In selected patients, magnetic resonance 
imaging (MRI) or positron emission tomography 
(PET) scans were performed. In all cases evaluation 
of the tumour’s hormonal activity was performed 
(plasma cortisol, urinary free cortisol, aldosterone, 
urinary aldosterone, plasma renin activity, me-
thoxycatecholamines and vanillylmandelic acid, 
adrenocorticotropin, dexamethasone suppression 
test, dehydroepiandrostenedione, 17-OH-proges-
terone, testosterone). 
We evaluated factors that potentially may in-
fluence LOS (primary length of stay after surgery, 
excluding readmissions). Our analysis included: 
gender, age, body mass index (BMI), distance from 
patient’s home to hospital, risk of anaesthesia mea-
sured with American Society of Anaesthesiologists 
(ASA) score, diabetes, cardiovascular disease and 
other comorbidities, history of previous abdominal 
surgery, hormonal activity, radiographic tumour size 
(largest diameter measured on adrenal-CT or MRI), 
side, histopathology and character of the tumour, 
operative time, day of operation (day of the week), 
intraoperative blood loss, complications and conver-
sions to open surgery.
All procedures were performed in accordance with 
the ethical standards laid down in the 1964 Decla-
ration of Helsinki and its later amendments. Written 
informed consent for the proposed surgical treatment 
was obtained from all patients before surgery.
The entire study group consisted of 453 patients 
(280 women and 173 men). The mean age was 
57 years (18–87 years). Three hundred and nine-
ty-eight patients were operated on for benign neo-
plasms, 55 for malignant tumours. The demographic 
analysis of the group is shown in Table I.
Table I. Demographic analysis of patient groups
Parameter Value
Number of patients 453
Females, n (%) 280 (61.8)
Males, n (%) 173 (38.2)
Age, mean ± SD [years] 56.68 ±13.5
ASA 1, n (%) 21 (4.6)
ASA 2, n (%) 253 (55.8)
ASA 3, n (%) 173 (38.2)
ASA 4, n (%) 6 (1.3)
Any comorbidity, n (%) 355 (78.4)
Cardiovascular, n (%) 116 (25.6)
Hypertension, n (%) 284 (62.7)
Diabetes, n (%) 126 (27.8)
Pulmonary disease, n (%) 63 (13.9)
Renal disease, n (%) 20 (4.4)
Liver disease, n (%) 11 (2.4)
Previous abdominal surgery, n (%) 209 (46.1)
Right suprarenal tumour, n (%) 223 (49.2)
Left suprarenal tumour, n (%) 230 (50.8)
Benign tumour, n (%) 398 (87.9)
Malignant tumour, n (%) 55 (12.1)
Operative time, mean ± SD [min] 97.0 ±39.0
Operative time, median (IQR) [min] 90 (70–120)
Intraoperative blood loss, mean ± SD [ml] 88.7 ±194.4
Intraoperative blood loss, median (IQR) [ml] 50 (20–70)
Conversion, n (%) 5 (1.1)
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Statistical analysis
All data were analysed with StatSoft Statistica 
v.10. The results are presented as mean ± standard 
deviation (SD) or median with interquartile range 
(IQR) when appropriate. Prolonged LOS was defined 
as discharge from hospital after more than calcu-
lated median hospital stay. A univariate logistic re-
gression analysis of individual demographic and 
perioperative parameters was undertaken to assess 
factors influencing prolonged LOS. Finally, the vari-
ables in the univariate logistic regression analysis 
that had a significant impact on the length of hos-
pital stay were used to build a multivariate logistic 
regression model. Results were considered statisti-
cally significant when the p-value was found to be 
less than 0.05.
Results
The median LOS in the entire group was 2 days. 
Length of hospital stay was consider as prolonged if 
it was longer than 2 days. Only 175 (38.5%) patients 
required hospitalization longer than 2 days (Figure 1). 
Mean operative time in the entire group was 97.0 
±39.0 min and mean intraoperative blood loss was 
88.7 ±194.4 ml. Conversion was performed in 5 pa-
tients. The reasons for conversion were: adhesions 
after previous surgery, abnormal location of the tu-
mour, infiltration to adjacent organs, damage to the 
tumour capsule and uncontrolled bleeding in 2 cas-
es. Table II presents postoperative outcomes in the 
analysed group.
Postoperative complications occurred in 35 (7.7%) 
patients, with 6 (1.3%) being severe (Clavien-Dindo 
3-5) (Table III). Readmission within 30 days after dis-
charge was necessary in 7 (1.55%) patients.
Univariate logistic regression showed that: 
presence of any comorbidity (OR = 1.65; 95% CI: 
1.02–2.68), cardiovascular disease (OR = 1.79; 95% 
Figure 1. Length of hospital stay in analysed group
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Table II. Postoperative outcomes in analysed 
groups
Parameter Value
Patients with complications, n (%) 35 (7.7)
Clavien-Dindo 1, n (%) 19 (4.2)
Clavien-Dindo 2, n (%) 10 (2.2)
Clavien-Dindo 3, n (%) 2 (0.4)
Clavien-Dindo 4, n (%) 3 (0.7)
Clavien-Dindo 5, n (%) 1 (0.2)
Length of hospital stay, mean ± SD [days] 2.5 ±1.5
Length of hospital stay [days], median (IQR) 2 (2–3)
Readmission, n (%) 7 (1.5%)
Table III. Complications in analysed groups
Complications Value
I Surgical site infection 5
Wound haematoma 2
Postoperative nausea and vomiting 3
Arrhythmia 2
Post-operative confusion 1
Fever 4
Non-infectious diarrhoea 1
C. difficile infection 1
II Deep vein thrombosis 1
Haemodynamic instability 4
Pneumonia 3
Urinary tract infection 1
Pleural effusion 1
III Intraperitoneal haematoma 1
Trocar-related bleeding 1
IV Pulmonary embolism 1
Respiratory failure 1
Heart infarct 1
V Mortality 1
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CI: 1.17–2.75), intraoperative complications (OR = 
2.14; 95% CI: 1.06–4.32), postoperative complica-
tions (OR = 3.86; 95% CI: 1.84–8.04), day of the 
week of operation (surgery on Thursday or Friday) 
(OR = 3.75; 95% CI: 2.52–5.58), intraoperative blood 
loss (> 90 ml) (OR = 1.74; 95% CI: 1.12–2.71), need 
for transfusion (OR = 15.02; 95% CI: 1.89–119.61), 
hormonal activity (OR = 1.61; 95% CI: 1.10–2.35), 
need for drainage (OR = 3.52; 95% CI: 1.71–7.25), 
ASA (III–IV) (OR = 1.92; 95% CI: 1.31–2.83), and 
histological type – pheochromocytoma (OR = 1.95; 
95% CI: 1.17–3.25) were related to prolonged LOS 
(Table IV). 
Next, the multivariate logistic regression mod-
el showed that only the presence of postoperative 
complications (OR = 3.86; 95% CI: 1.84–8.04), day 
of the week (Thursday or Friday) (OR = 4.85; 95% CI: 
3.04–7.73), need for drainage (OR = 3.63; 95% CI: 
1.55–8.52) and histological type – pheochromocyto-
ma (OR = 2.48; 95% CI: 1.35–4.54) were significant 
factors prolonging LOS. Gender, BMI, presence of 
previous abdominal surgery, presence of comorbidi-
ties, tumour side, and ASA had no effect on primary 
length of hospital stay (Table V).
Discussion 
Our study showed that there are several unrelat-
ed factors affecting prolonged LOS in patients un-
dergoing laparoscopic adrenalectomy. These factors 
include presence of postoperative complications, 
day of the week of the operation (Thursday or Fri-
Table IV. Univariate logistic regression affecting prolonged hospitalization (> 2 days)
Parameter OR 95% CI P-value
Sex (female vs. male) 0.88 0.60–1.30 0.5293
Age [years] 1.00 0.99–1.02 0.6215
BMI [kg/m2] 0.99 0.96–1.02 0.4877
Previous abdominal surgery (yes vs. no) 1.11 0.75–1.62 0.6118
Any comorbidity (yes vs. no) 1.65 1.02–2.68 0.0418
Diabetes (yes vs. no) 1.40 0.92–2.12 0.1154
Cardiovascular disease (yes vs. no) 1.79 1.17–2.75 0.0074
Tumour site (right vs. left) 0.86 0.59–1.25 0.4235
Intraoperative complications (yes vs. no) 2.14 1.06–4.32 0.0350
Complications (yes vs. no) 3.86 1.84–8.04 0.0004
Conversion (yes vs. no) 6.48 0.72–58.46 0.0959
Day of the week 3.75 2.52–5.58 < 0.0001
Operative time (> 120 vs. ≤ 120 min) 1.49 0.98–2.24 0.0596
Need for transfusion 15.02 1.89–119.61 0.0105
Blood loss (> 90 vs. ≤ 90 ml) 1.74 1.12–2.71 0.0141
Drainage 3.52 1.71–7.25 0.0006
ASA (III–IV vs. I–II) 1.92 1.31–2.83 0.0009
Hormonal activity (yes vs. no) 1.61 1.10–2.35 0.0152
Distance from home 1.00 1.00–1.00 0.7952
Pheochromocytoma 1.95 1.17–3.25 0.0101
Tumour character (malignant vs. benign) 1.16 0.65–2.05 0.6146
Size of the tumour [cm] 1.05 0.97–1.14 0.2150
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day), need for drainage, and histological type of the 
tumour – pheochromocytoma. 
Median LOS in our study group was 2 days. Only 
38.5% of the patients required hospitalization lon-
ger than 2 days, which we set as the cut-off point 
for stating prolonged LOS. More than 61.3% of pa-
tients were discharged on postoperative day 1 or 
day 2. Similar LOS was reported by Karabulut et al. 
and Pineda-Solis et al., whereas Shi et al. and Wang 
et al.  report their LOS to be 5–6 days [7, 8, 13, 14]. 
Such short hospital stays in our unit are the result of 
several factors. First of all, our department is part of 
tertiary referral university hospital with a high annu-
al volume of laparoscopic adrenalectomies (around 
60 per year). In a previously published study, based 
on 500 adrenalectomies performed in our unit, it was 
proven that both surgical experience and periopera-
tive care lead to reduced LOS [15]. Secondly, over the 
years the perioperative care has improved, which 
also affected the outcomes [16–19].
Length of hospital stay is inextricably related to 
the extent of the surgery and the patient’s general 
condition in the postoperative period. The classical 
approach and the occurrence of complications are 
undoubtedly reasons for prolonged hospital stay. 
Most cases of open adrenalectomy require a much 
longer hospital stay, and discharges after 24 to 48 h 
are rare. Due to the fact that since 2003 almost all 
adrenalectomies have been performed with min-
imally invasive access, open procedures are per-
formed mainly in cases of conversion. The conver-
sion rate in our group was relatively low (1.1%). In 
addition, there was a  small proportion of patients 
operated on using single access. We did not observe 
any shortening of LOS despite the reduction of the 
number of trocars. It seems that the only benefit 
of the approach is a minor cosmetic improvement, 
but at the cost of a  longer operative time [20, 21]. 
Therefore this technique still remains questionable. 
Another factor quite obviously related to prolonged 
LOS is complications. On the other hand, the rate of 
severe complications in our group was relatively low. 
Therefore, we tried to determine which other factors 
(demographic and perioperative) may allow predic-
tion of the necessity for prolonged hospitalization.
We observed that the histological type of the tu-
mour being pheochromocytoma affects the length 
of hospital stay, which was proven in the multivari-
ate logistic regression model. These patients require 
special care in the perioperative period. The morbid-
ity rate is greater and ranges from 5% to 23% [22]. 
In addition, surgery for pheochromocytoma is con-
sidered more difficult compared to other tumours 
[23]. The most important complication in this study 
group is haemodynamic instability in the periopera-
tive period [24]. It may often require catecholamine 
infusion, even up to several days after the surgery. 
Similar conclusions, regarding LOS in patients with 
pheochromocytoma, were drawn by other authors. 
Conzo et al. reported LOS of 4 days, Kim et al. almost 
6 days and Gagner et al. over 8 days [6, 25, 26]. On 
the other hand, Kercher et al. reported a short time 
Table V. Multivariate logistic regression affecting prolonged hospitalization (> 2 days)
Parameter OR 95% CI P-value
Any comorbidity (yes vs. no) 1.15 0.63–2.11 0.6519
Cardiovascular disease (yes vs. no) 1.31 0.73–2.36 0.3667
Day of the week 4.85 3.04–7.73 < 0.0001
Hormonal activity (yes vs. no) 1.34 0.85–2.13 0.2117
Intraoperative complications (yes vs. no) 0.95 0.27–3.31 0.9329
Complications (yes vs. no) 3.86 1.84–8.04 < 0.0001
Need for transfusion 7.55 0.58–98.76 0.1233
Blood loss (> 90 vs. ≤ 90 ml) 1.26 0.62–2.55 0.5180
Need of drainage 3.63 1.55–8.52 0.0031
ASA (III–IV vs. I–II) 1.42 0.82–2.46 0.2060
Pheochromocytoma 2.48 1.35–4.54 0.0133
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of hospitalization, 2 to 3 days, and a relatively low 
morbidity rate of 4% [27]. Similar short LOS were re-
ported by Cheah et al. and Jaroszewski et al. [28, 29]. 
Such vast diversity in LOS is mainly caused by the 
differences in reported complication rate, including 
the most important one – haemodynamic instabil-
ity. Some authors have reported that patients with 
different hormonal activity of the tumours such as 
patients with Cushing syndrome, who require ste-
roid supplementation in the perioperative period, 
may have prolonged hospitalization. In most cases, 
early introduction of an oral diet, early mobilization 
and optimal analgesic protocol allow hospitalization 
to be shortened, while steroid supplementation is 
continued after discharge orally.
Another factor significantly prolonging hospital-
ization is postoperative drainage. It is not routine-
ly used in our centre, which supports the idea of 
modern perioperative care. In one study, Major et al. 
showed that drainage after laparoscopic adrenalec-
tomy is not only unnecessary, but may also be asso-
ciated with an increased risk of complications [30]. 
In our unit the use of drains was justified only when 
there was an increased risk of postoperative bleed-
ing, and they were removed as soon as possible.
The last factor significantly extending LOS was 
the day of the week on which the surgery was per-
formed. The operation being on Thursday and Friday 
was related to a longer stay as a result of the reluc-
tance to discharge patients during the weekend. 
Intraoperative blood loss and duration of surgery 
were the next possible factors prolonging LOS. How-
ever, the multivariate regression model revealed that 
these factors had no significant impact. It may seem 
that these parameters are associated with intraop-
erative difficulties, which in turn may increase the 
risk of complications. Because of that, the multivar-
iate regression model shows that the morbidity has 
a significant impact on the length of hospital stay. 
Our study has limitations associated with the 
single centre design. Another limiting factor is the 
fact that throughout this period, the perioperative 
care protocol in our unit has been modified and the 
proficiency in laparoscopic surgery has increased. 
These factors may bias our results. 
Conclusions
Our study has proven that the tumour histolog-
ical type being pheochromocytoma, postoperative 
complications, operation at the end of the week (on 
Thursday or Friday), and the need for drainage may 
cause prolonged LOS in patients undergoing laparo-
scopic adrenalectomy. 
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